Tuberculosis (TB) Drugs Market
                     Student Information 
SystemMarket
Tuberculosis (TB) 
Drugs Market
Outlook, Growth Factors, Industry 
Share,  Size By 2026
Sample View Report
https://straitsresearch.co +1 6464807505, +44 203 sales@straitsresearc
m/ 318 2846 h.com
Tuberculosis (TB) 
Drugs Market
Tuberculosis (TB) Drugs Market Outlook, Growth Factors, 
Industry  Share, Size by 2026| Straits Research
Tuberculosis (TB) infection treatment comprises of 4 drug regimen isoniazid, rifampin, 
pyrazinamide, and either ethambutol or streptomycin to sterile or kill the Mycobacterium 
bacteria. First line TB drugs are Isoniazid, Pyrazinamide, Ethambutol, Rifampicin. In second line of 
therapy, the drug combination varies as well as the drug dosage is increased because of 
resistance developed by the bacteria during first line of therapy. Patients undergo retreatment 
should be referred for a rapid molecular test or drug susceptibility testing to determine at 
rifampicin resistance importantly isoniazid resistance. According to WHO, in 2016, around 1.3 
million deaths were reported among HIV negative people, additionally, 374,000 deaths were 
reported in HIV Positive people.  In 2016, 10.4 million people fell ill among them 90% were adults 
and 65% were male. Due to this increasing number of tuberculosis and increasing awareness 
among people drive the tuberculosis drug market.
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com
Tuberculosis (TB) 
Drugs Market
The global tuberculosis drugs market was valued at around USD 895.5 million in 2017 and is 
anticipated to exhibit a CAGR of 6.3% during the forecast period. 
Click Here to Access the Sample Report:
https://
straitsresearch.com/report/global-tuberculosis-drugs-market/request-sample
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com
Tuberculosis (TB) 
Drugs Market
Tuberculosis (TB) Drugs Market Players Covered in This Report:
• Sigma Pharmaceutical Pty Limited, 
• Aventis Pharmaceuticals Limited,
• Novartis AG, 
• Sanofi Aventis U.S LLC, 
• Hoffmann-La Roche Ltd, 
• Akorn, Incorporated, 
• Bayer Health care.
A Summary of the Impact of COVID-19 on this Market:
The appearance of  COVID-19 has transported the globe to a halt. We understand that this 
health  disaster has brought an unprecedented impact on businesses across industries. 
However, this too  shall pass. Growing support from governments and various companies 
can benefit in the fight  against this highly transmissible disease. There are some 
businesses that are struggling and some  are thriving. General, almost every sector is 
anticipated to be stuck by the pandemic.    
     
                                                  Get This Full Report from Here:
                            https://straitsresearch.com/report/global-tuberculosis-drugs-market
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com
Tuberculosis (TB) 
Drugs Market
The Tuberculosis (TB) Drugs Market has been segmented as below:
By Disease Type
• Active TB
• Latent TB
By Therapy
• First-Line Therapy
• Second-Line Therapy
By Region
• North America
• Europe
• Asia Pacific
• Latin America and Middle East & Africa
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com
Student Information 
SystemMarket
About Straits Research
StraitsResearch.com is a leading market research and market 
intelligence  organization, specializing in research, analytics, and 
advisory services along with  providing business insights & market 
research reports.
https://straitsresearch.com/
825 3rd Avenue, New York, NY, 
USA,
+1 6464807505, +44 203 318 
2846
[email protected]
https://straitsresearch.co +1 6464807505, +44 sales@straitsresearc
m/ 203 318 h.com